Trending Now
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) To Commence Construction of New...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to hold a groundbreaking ceremony at its planned 45,000 sq. ft. clinical scale manufacturing plant in the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BioCardia (NASDAQ:BCDA) Receives Positive Recommendation To Continue Piboatl CardiAMP™ Heart Failure...
BioCardia (NASDAQ:BCDA) has announced the completion of its pre-specified data review for its third phase pivotal CardiAMP™ Heart Failure Trial. The independent...
MAKE IT MODERN
LATEST REVIEWS
Design Therapeutics Inc (NASDAQ: DSGN) Will Present GeneTAC Therapy Results
Design Therapeutics Inc (NASDAQ: DSGN) announced it would represent preclinical data on its GeneTAC therapy. The company developed this treatment for Fuchs endothelial corneal...
MAKE IT MODERN
PERFORMANCE TRAINING
Sorrento Therapeutics Inc (NASDAQ: SRNE) Gives an Update on STI 9167
Sorrento Therapeutics Inc (NASDAQ: SRNE) recently revealed that it had received the relevant authority from the Food and Drug Administration to proceed...
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan Drug Designation RGLS8429
Regulus Therapeutics Inc (NASDAQ: RGLS) is pleased after the U.S. Food and Drug Administration (FDA) made its determination and approved its orphan drug designation...
Galecto Inc (NASDAQ: GLTO) Enrolls Patients in GULLIVER-2 Study
Galecto Inc (NASDAQ: GLTO) has enrolled patients for the second and third parts of its Phase Ib/IIa GB1211, GULLIVER-2 study. The company...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Issued Its Shareholders and Investors With an Update...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) recently declared that Dr Frederike Holze and Dr Matthias Lietchi would be the person to give an update...
Nikola Corporation (NASDAQ: NKLA) Announces $143,231 Loss in The Second Quarter of 2021
Nikola Corporation (NASDAQ: NKLA), a US-based zero-emissions transportation company, recently reported its financial results for the three months ending June 30, 2021. The company...
MAKE IT MODERN
